Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Exploratory validation of a multidimensional power wheelchair outcomes toolkit.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy).
Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Spinal Cord Diffusion-Tensor Imaging and Motor-evoked Potentials in Multiple Sclerosis Patients: Microstructural and Functional Asymmetry.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Structural brain lesions in inflammatory bowel disease.

Pages